Skip to main content

Table 2 Management shows significant differences between areas

From: Reduced cardiac function and risk of venous thromboembolism in Asian countries

Management

Western countries

China

Japan

Volume loading

250–500 ml

500 ml

None

Anticoagulation therapy

Recommended in PE patients with HF

Recommended in PE patients with HF

For normotensive PE patients without right heart dysfunction

Thrombolytic therapy

Considered for PE patients with HF without contradictions

Recommended in PE patients with HF without contradictions

For PE patients with persistent shock and hypotension

Anticoagulation drugs

NOACs combined parenteral anticoagulation

Unfractionated heparin only except in few medical centers

Unfractionated heparin only except in few medical centers

Thrombolytic drugs

Tenecteplase

Monteplase

Alteplase, reteplase, urokinase